Drug Side Effects

SULFASALAZINE

SULFASALAZINE was reported 77781 times

SULFASALAZINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 79 0.9186
1 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 304 0.9075
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5597 0.7979
3 RED BLOOD CELL SEDIMENTATION RATE 212 0.7626
4 SWOLLEN JOINT COUNT INCREASED 2295 0.7454
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 487 0.7390
6 RHEUMATOID FACTOR POSITIVE 4138 0.7266
7 LUPUS VULGARIS 844 0.7183
8 RHEUMATIC FEVER 3055 0.7085
9 HEPATIC ENZYME 93 0.6739
10 PEMPHIGUS 8068 0.6575
11 DUODENAL ULCER PERFORATION 4720 0.6514
12 DEEP VEIN THROMBOSIS POSTOPERATIVE 1252 0.6467
13 C-REACTIVE PROTEIN 558 0.6228
14 GRANULOMA SKIN 507 0.6198
15 MUSCULOSKELETAL DEFORMITY 138 0.5923
16 HAND DEFORMITY 7498 0.5807
17 C-REACTIVE PROTEIN ABNORMAL 3578 0.5659
18 RHEUMATOID FACTOR NEGATIVE 98 0.5600
19 SWOLLEN JOINT COUNT 135 0.5556
20 FACET JOINT SYNDROME 1686 0.5418
21 GRIP STRENGTH 123 0.5371
22 SYNOVITIS 9222 0.5178
23 X-RAY ABNORMAL 888 0.5043
24 BODY HEIGHT BELOW NORMAL 315 0.4907
25 DISLOCATION OF VERTEBRA 1073 0.4884
26 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 969 0.4869
27 PRESBYACUSIS 147 0.4788
28 HELICOBACTER INFECTION 4755 0.4726
29 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1073 0.4673
30 RETINITIS 743 0.4508
31 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2798 0.4403
32 SERONEGATIVE ARTHRITIS 483 0.4359
33 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 228 0.4238
34 MUSCLE INJURY 3407 0.4206
35 BONE EROSION 1423 0.4068
36 BLOOD PARATHYROID HORMONE DECREASED 593 0.4026
37 HYPOCHOLESTEROLAEMIA 122 0.4013
38 FOLLICULITIS 3905 0.3829
39 PERICARDITIS 5998 0.3647
40 GLOSSODYNIA 7851 0.3559
41 PERIPHERAL VENOUS DISEASE 1394 0.3536
42 BLOOD IRON ABNORMAL 340 0.3509
43 DRUG TOLERANCE DECREASED 916 0.3314
44 CONTRAINDICATED PRODUCT ADMINISTERED 9681 0.3252
45 ENTHESOPATHY 478 0.3070
46 INTESTINAL SEPSIS 75 0.3000
47 RHEUMATOID NODULE 761 0.2769
48 PANNICULITIS 633 0.2660
49 JOINT DESTRUCTION 410 0.2655
50 WOUND 7003 0.2552
51 SYSTEMIC LUPUS ERYTHEMATOSUS 8877 0.2543
52 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2551 0.2331
53 GRIP STRENGTH DECREASED 1988 0.2302
54 BREAST CANCER STAGE III 1453 0.2288
55 RED CELL DISTRIBUTION WIDTH DECREASED 103 0.2259
56 STEROID DEPENDENCE 182 0.2169
57 TENOSYNOVITIS STENOSANS 119 0.2156
58 ANKLE ARTHROPLASTY 76 0.2147
59 WRIST DEFORMITY 131 0.2141
60 OVERLAP SYNDROME 143 0.2100
61 SYNOVIAL DISORDER 94 0.2094
62 NECK DEFORMITY 92 0.2072
63 ONYCHOMADESIS 820 0.2000
64 JOINT RANGE OF MOTION DECREASED 2627 0.1991
65 DACTYLITIS 192 0.1981
66 LIP DRY 1690 0.1911
67 PORPHYRIA ACUTE 258 0.1893
68 IRRITABLE BOWEL SYNDROME 3935 0.1866
69 JOINT ANKYLOSIS 104 0.1841
70 PLEURAL THICKENING 123 0.1828
71 JOINT SPACE NARROWING 53 0.1803
72 CATARRH 158 0.1800
73 DISABILITY ASSESSMENT SCALE SCORE INCREASED 55 0.1792
74 RHEUMATOID ARTHRITIS 19529 0.1750
75 HYPERCHOLESTEROLAEMIA 1624 0.1719
76 BURSITIS 2007 0.1685
77 ARTHROPATHY 9217 0.1674
78 ONYCHOMYCOSIS 719 0.1663
79 ANTIBODY TEST POSITIVE 273 0.1648
80 WOUND INFECTION 1739 0.1621
81 JUVENILE IDIOPATHIC ARTHRITIS 384 0.1588
82 PLEURAL FIBROSIS 157 0.1544
83 THERAPEUTIC PRODUCT EFFECT DECREASED 6745 0.1540
84 FINGER DEFORMITY 723 0.1511
85 NAIL OPERATION 61 0.1502
86 PSORIATIC ARTHROPATHY 5937 0.1496
87 FIBROMYALGIA 3501 0.1461
88 BLEPHAROSPASM 894 0.1460
89 DRUG INTOLERANCE 13762 0.1449
90 MEAN PLATELET VOLUME DECREASED 115 0.1402
91 LIVE BIRTH 1149 0.1398
92 POLYARTHRITIS 717 0.1383
93 VASCULAR ACCESS COMPLICATION 109 0.1364
94 AUTOIMMUNE DISORDER 1266 0.1340
95 BLOOD MAGNESIUM INCREASED 118 0.1321
96 SOFT TISSUE SWELLING 73 0.1318
97 LIVER INJURY 3080 0.1290
98 IMPAIRED HEALING 4156 0.1283
99 BONE DENSITY INCREASED 49 0.1241
100 C-REACTIVE PROTEIN INCREASED 4435 0.1236
101 ARTHRODESIS 124 0.1235
102 NAIL DISORDER 1048 0.1222
103 BONE CYST 113 0.1218
104 RHEUMATOID LUNG 113 0.1188
105 OBESITY 1866 0.1185
106 BLOOD PRESSURE DIASTOLIC ABNORMAL 298 0.1175
107 SCIATICA 1835 0.1172
108 EXOSTOSIS 1039 0.1154
109 INFUSION SITE REACTION 329 0.1147
110 BLOOD PRESSURE SYSTOLIC ABNORMAL 278 0.1131
111 INFUSION RELATED REACTION 7360 0.1129
112 DEATH NEONATAL 153 0.1126
113 FOOT DEFORMITY 1230 0.1123
114 TYPE 2 DIABETES MELLITUS 3697 0.1109
115 TREATMENT FAILURE 8899 0.1099
116 MATERNAL EXPOSURE TIMING UNSPECIFIED 398 0.1084
117 ALANINE AMINOTRANSFERASE ABNORMAL 224 0.1081
118 JOINT SWELLING 12743 0.1072
119 PULMONARY FIBROSIS 2021 0.1071
120 HIP ARTHROPLASTY 1594 0.1064
121 HEPATIC ENZYME INCREASED 7041 0.1050
122 SKIN NECROSIS 538 0.1047
123 TRANSPLANT DYSFUNCTION 179 0.1030
124 SPONDYLOARTHROPATHY 59 0.1002
125 INFLAMMATORY PAIN 67 0.1001
126 DRUG SPECIFIC ANTIBODY 132 0.0980
127 DISCOMFORT 5860 0.0979
128 BLOODY DISCHARGE 111 0.0977
129 APPARENT DEATH 348 0.0966
130 PUSTULAR PSORIASIS 326 0.0958
131 SWELLING 8705 0.0945
132 BURNS SECOND DEGREE 163 0.0944
133 SACROILIITIS 173 0.0924
134 EXTREMITY CONTRACTURE 58 0.0916
135 LUPUS-LIKE SYNDROME 806 0.0906
136 KNEE ARTHROPLASTY 1860 0.0904
137 C-REACTIVE PROTEIN DECREASED 58 0.0902
138 OSTEOARTHRITIS 3747 0.0894
139 BONE SWELLING 84 0.0874
140 LOWER RESPIRATORY TRACT INFECTION 3892 0.0870
141 WALKING AID USER 568 0.0869
142 MUSCULOSKELETAL STIFFNESS 7471 0.0864
143 JOINT ARTHROPLASTY 141 0.0796
144 BLOOD CHOLESTEROL INCREASED 3644 0.0792
145 BACK INJURY 841 0.0787
146 MEAN CELL VOLUME DECREASED 120 0.0786
147 LOWER LIMB FRACTURE 1475 0.0783
148 DRUG TOLERANCE 391 0.0780
149 BLISTER 4299 0.0778
150 JOINT DISLOCATION 807 0.0777
151 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3638 0.0775
152 PRODUCT LABEL CONFUSION 439 0.0765
153 INTERNATIONAL NORMALISED RATIO FLUCTUATION 156 0.0754
154 PRESCRIBED OVERDOSE 1432 0.0750
155 INFLAMMATION 3777 0.0746
156 LIVER FUNCTION TEST INCREASED 1569 0.0745
157 SPONDYLITIS 267 0.0745
158 MYCOTIC ALLERGY 61 0.0733
159 STOMATITIS 4375 0.0731
160 JOINT EFFUSION 490 0.0717
161 MEAN CELL HAEMOGLOBIN DECREASED 130 0.0717
162 GAIT INABILITY 2340 0.0716
163 SCLERITIS 109 0.0692
164 LARYNGITIS 737 0.0688
165 MOBILITY DECREASED 4858 0.0687
166 BONE MARROW OEDEMA 70 0.0684
167 COELIAC DISEASE 655 0.0676
168 JOINT STIFFNESS 1726 0.0666
169 MATERNAL EXPOSURE DURING PREGNANCY 5674 0.0652
170 BLOOD FOLATE DECREASED 46 0.0644
171 BREAST CANCER STAGE II 533 0.0643
172 PRESCRIBED UNDERDOSE 1223 0.0621
173 ULCER HAEMORRHAGE 411 0.0615
174 WHEELCHAIR USER 269 0.0610
175 ABDOMINAL DISCOMFORT 10045 0.0609
176 ANKYLOSING SPONDYLITIS 782 0.0608
177 TUBERCULIN TEST POSITIVE 154 0.0608
178 SYNOVIAL CYST 275 0.0600
179 RHEUMATIC DISORDER 114 0.0594
180 MUSCULOSKELETAL PAIN 3097 0.0594
181 EYE INJURY 176 0.0592
182 NIGHT SWEATS 1844 0.0580
183 SPINAL STENOSIS 231 0.0573
184 RASH VESICULAR 267 0.0562
185 ILL-DEFINED DISORDER 3364 0.0561
186 AXIAL SPONDYLOARTHRITIS 46 0.0552
187 CONGENITAL ANOMALY 423 0.0550
188 FINE MOTOR SKILL DYSFUNCTION 156 0.0549
189 HEPATIC CIRRHOSIS 999 0.0542
190 LIMB DEFORMITY 85 0.0539
191 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3597 0.0515
192 DISABILITY 1005 0.0515
193 HYPERCALCAEMIA 621 0.0510
194 DEFORMITY 467 0.0505
195 ALLERGY TO CHEMICALS 62 0.0504
196 OSTEOSCLEROSIS 78 0.0501
197 LYMPHADENECTOMY 48 0.0497
198 TENDERNESS 510 0.0495
199 BRONCHIECTASIS 324 0.0493
200 GASTROINTESTINAL DISORDER 4278 0.0490
201 ANTINUCLEAR ANTIBODY POSITIVE 158 0.0490
202 THYROID NEOPLASM 135 0.0490
203 ALOPECIA 9474 0.0488
204 DEAFNESS NEUROSENSORY 157 0.0485
205 CREPITATIONS 143 0.0482
206 BASAL CELL CARCINOMA 739 0.0480
207 HYPOPNOEA 162 0.0475
208 LUNG DISORDER 2290 0.0474
209 SPINAL FUSION SURGERY 187 0.0472
210 WHEEZING 2748 0.0471
211 HEPATIC ENZYME ABNORMAL 231 0.0470
212 INTENTIONAL PRODUCT USE ISSUE 4013 0.0462
213 PRURITUS ALLERGIC 53 0.0460
214 INJURY 3168 0.0454
215 BLADDER TRANSITIONAL CELL CARCINOMA 64 0.0451
216 ADRENAL INSUFFICIENCY 529 0.0448
217 NEOPLASM SKIN 68 0.0443
218 DRUG HYPERSENSITIVITY 8460 0.0441
219 DRUG ERUPTION 765 0.0440
220 ARTHRITIS 3417 0.0439
221 GENERAL PHYSICAL HEALTH DETERIORATION 4965 0.0438
222 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 142 0.0437
223 NODULE 561 0.0436
224 LIVER DISORDER 1891 0.0432
225 MONOCYTE COUNT INCREASED 154 0.0429
226 IMMOBILE 184 0.0429
227 PRERENAL FAILURE 59 0.0428
228 HEPATITIS 1077 0.0426
229 SLEEP DISORDER 2942 0.0426
230 TASTE DISORDER 842 0.0426
231 THERAPY NON-RESPONDER 1870 0.0425
232 CUSHINGOID 135 0.0423
233 PLEURITIC PAIN 115 0.0420
234 HYPERSENSITIVITY 7607 0.0416
235 NECK MASS 116 0.0415
236 PULMONARY TOXICITY 286 0.0413
237 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 96 0.0411
238 MACROCYTOSIS 47 0.0408
239 SINUSITIS 4134 0.0408
240 BLOOD PRESSURE DIASTOLIC INCREASED 186 0.0407
241 ALCOHOL POISONING 106 0.0405
242 ULCER 634 0.0403
243 EPIGASTRIC DISCOMFORT 156 0.0403
244 INFECTION 5717 0.0402
245 OEDEMA 2126 0.0398
246 SMEAR CERVIX ABNORMAL 56 0.0397
247 ROAD TRAFFIC ACCIDENT 1632 0.0395
248 SKIN ULCER 1003 0.0394
249 NORMAL NEWBORN 209 0.0390
250 INVESTIGATION ABNORMAL 53 0.0385
251 WHITE BLOOD CELL COUNT ABNORMAL 242 0.0385
252 DRUG-INDUCED LIVER INJURY 1157 0.0380
253 GASTROINTESTINAL TOXICITY 176 0.0379
254 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 607 0.0366
255 ADVERSE REACTION 477 0.0364
256 CONTUSION 3431 0.0362
257 TONGUE DISORDER 260 0.0361
258 LYME DISEASE 118 0.0360
259 SHOULDER ARTHROPLASTY 93 0.0355
260 PREGNANCY 707 0.0354
261 PHYSICAL DISABILITY 155 0.0353
262 OSTEOPOROSIS 1392 0.0343
263 DIVERTICULITIS 932 0.0342
264 HEPATOTOXICITY 743 0.0340
265 COLITIS MICROSCOPIC 157 0.0339
266 INFLAMMATORY MARKER INCREASED 163 0.0337
267 EXPOSURE DURING PREGNANCY 2065 0.0337
268 BONE DENSITY ABNORMAL 125 0.0336
269 FOOD INTOLERANCE 119 0.0330
270 ARTHRALGIA 13482 0.0330
271 EPICONDYLITIS 49 0.0329
272 ARTHRITIS BACTERIAL 130 0.0323
273 FEAR OF INJECTION 222 0.0322
274 CONDITION AGGRAVATED 9594 0.0322
275 BLOOD PRESSURE SYSTOLIC INCREASED 619 0.0320
276 DELIRIUM 1092 0.0320
277 BLOOD PRESSURE DIASTOLIC DECREASED 234 0.0320
278 NECK PAIN 1764 0.0319
279 PRODUCT USE ISSUE 5811 0.0315
280 GRANULOMA 107 0.0313
281 IMPAIRED WORK ABILITY 650 0.0307
282 IMMUNODEFICIENCY 444 0.0305
283 ROTATOR CUFF REPAIR 52 0.0304
284 NASOPHARYNGITIS 5445 0.0299
285 COSTOCHONDRITIS 48 0.0298
286 EPILEPSY 887 0.0295
287 DRY MOUTH 2335 0.0292
288 MYOSITIS 256 0.0289
289 HEPATIC FIBROSIS 96 0.0285
290 UVEITIS 379 0.0284
291 RHINITIS 226 0.0284
292 BLOOD PRESSURE FLUCTUATION 674 0.0284
293 TENDONITIS 432 0.0281
294 LATENT TUBERCULOSIS 58 0.0281
295 FREQUENT BOWEL MOVEMENTS 739 0.0278
296 EAR PAIN 533 0.0278
297 MUSCULOSKELETAL DISORDER 521 0.0276
298 EAR INFECTION 718 0.0274
299 JOINT INJURY 577 0.0273
300 RED CELL DISTRIBUTION WIDTH INCREASED 112 0.0273
301 TERMINAL STATE 180 0.0272
302 FOOT OPERATION 130 0.0268
303 INTERSTITIAL LUNG DISEASE 1271 0.0267
304 GENERAL SYMPTOM 198 0.0266
305 RENAL MASS 54 0.0265
306 PAIN 15948 0.0263
307 BODY TEMPERATURE DECREASED 256 0.0261
308 DERMATITIS ALLERGIC 320 0.0260
309 IRON DEFICIENCY 114 0.0260
310 OVARIAN CYST 257 0.0259
311 DEMYELINATION 105 0.0258
312 CYST 315 0.0257
313 RASH 10987 0.0257
314 CONFUSIONAL STATE 4046 0.0253
315 OSTEOPOROTIC FRACTURE 48 0.0252
316 PULMONARY THROMBOSIS 271 0.0251
317 JOINT NOISE 48 0.0251
318 DERMATITIS PSORIASIFORM 50 0.0248
319 THERAPEUTIC RESPONSE DECREASED 1477 0.0248
320 HYPERTENSION 5167 0.0247
321 ARTHRITIS INFECTIVE 113 0.0247
322 BREATH SOUNDS ABNORMAL 120 0.0247
323 DYSPEPSIA 2378 0.0246
324 MATERNAL EXPOSURE BEFORE PREGNANCY 163 0.0243
325 COLITIS ULCERATIVE 1062 0.0241
326 LYMPHOPROLIFERATIVE DISORDER 70 0.0241
327 SENSITIVITY TO WEATHER CHANGE 124 0.0240
328 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 57 0.0237
329 HYPOAESTHESIA 3498 0.0237
330 PAROSMIA 174 0.0234
331 TONGUE ULCERATION 78 0.0233
332 PYODERMA GANGRENOSUM 82 0.0233
333 PULMONARY MASS 341 0.0232
334 TUBERCULOSIS 293 0.0231
335 WEIGHT INCREASED 5075 0.0231
336 IRITIS 69 0.0230
337 GINGIVAL PAIN 180 0.0229
338 HYPERSENSITIVITY VASCULITIS 60 0.0229
339 TRANSPLANT REJECTION 180 0.0228
340 MIGRAINE 2124 0.0227
341 DRUG INEFFECTIVE 29356 0.0226
342 CARDIAC MURMUR 194 0.0226
343 BACK DISORDER 357 0.0222
344 URTICARIA 3580 0.0218
345 CARPAL TUNNEL SYNDROME 302 0.0218
346 OSTEOPENIA 319 0.0212
347 ADVERSE EVENT 1910 0.0210
348 PAIN IN EXTREMITY 6102 0.0210
349 ADVERSE DRUG REACTION 1829 0.0207
350 HEPATIC STEATOSIS 375 0.0204
351 JOINT LOCK 57 0.0203
352 LIVER FUNCTION TEST ABNORMAL 586 0.0203
353 PULMONARY TUBERCULOSIS 85 0.0202
354 ALANINE AMINOTRANSFERASE INCREASED 1216 0.0201
355 MULTIPLE ALLERGIES 155 0.0200
356 DISSEMINATED TUBERCULOSIS 50 0.0199
357 DRUG EFFECT INCOMPLETE 723 0.0199
358 SPINAL OSTEOARTHRITIS 172 0.0197
359 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 312 0.0195
360 RESPIRATORY DISORDER 578 0.0195
361 SPINAL PAIN 224 0.0194
362 LYMPHOMA 296 0.0194
363 LOCALISED INFECTION 461 0.0193
364 ONYCHOCLASIS 130 0.0192
365 DERMATOMYOSITIS 48 0.0192
366 PLATELET COUNT INCREASED 245 0.0190
367 RASH PRURITIC 999 0.0188
368 MUSCULOSKELETAL DISCOMFORT 317 0.0187
369 DYSLIPIDAEMIA 93 0.0185
370 BONE LESION 66 0.0185
371 IMPAIRED QUALITY OF LIFE 263 0.0185
372 WEIGHT FLUCTUATION 190 0.0185
373 PSORIASIS 2379 0.0184
374 GAIT DISTURBANCE 3464 0.0183
375 HERPES ZOSTER 1038 0.0183
376 MOUTH ULCERATION 376 0.0181
377 UPPER RESPIRATORY TRACT INFECTION 820 0.0180
378 WEIGHT BEARING DIFFICULTY 48 0.0180
379 MEDICATION ERROR 985 0.0180
380 GASTROOESOPHAGEAL REFLUX DISEASE 1411 0.0178
381 RECTAL HAEMORRHAGE 756 0.0178
382 MENISCUS INJURY 108 0.0178
383 ROTATOR CUFF SYNDROME 226 0.0178
384 AMNESIA 1125 0.0174
385 CHONDROPATHY 47 0.0174
386 ASPARTATE AMINOTRANSFERASE INCREASED 911 0.0174
387 FATIGUE 13318 0.0174
388 MULTIPLE-DRUG RESISTANCE 53 0.0173
389 ORAL DISCOMFORT 238 0.0173
390 ANAL FISSURE 91 0.0173
391 SARCOIDOSIS 81 0.0173
392 LYMPHOCYTE COUNT INCREASED 55 0.0171
393 PEPTIC ULCER 55 0.0168
394 VITAMIN B12 DECREASED 47 0.0166
395 PHOTOSENSITIVITY REACTION 268 0.0165
396 LIMB DISCOMFORT 501 0.0164
397 ANAL FISTULA 86 0.0163
398 ERYTHEMA NODOSUM 56 0.0162
399 INJECTION SITE REACTION 1096 0.0162
400 ATELECTASIS 154 0.0161
401 FOOT FRACTURE 301 0.0160
402 CANDIDA INFECTION 264 0.0160
403 SKIN REACTION 222 0.0160
404 ABDOMINAL PAIN UPPER 3202 0.0158
405 ANAPHYLACTIC REACTION 856 0.0158
406 ESCHERICHIA URINARY TRACT INFECTION 66 0.0157
407 TRIGGER FINGER 63 0.0157
408 PYREXIA 5363 0.0157
409 GASTRIC DISORDER 537 0.0156
410 HYPERTRANSAMINASAEMIA 105 0.0156
411 ASTHMA 1704 0.0154
412 GOITRE 62 0.0153
413 THROMBOCYTOSIS 55 0.0153
414 FIBROSIS 46 0.0152
415 BRONCHITIS 1112 0.0151
416 TOOTH INFECTION 196 0.0151
417 GASTROENTERITIS VIRAL 267 0.0149
418 PNEUMONIA 4748 0.0149
419 MUSCULAR WEAKNESS 1669 0.0149
420 PYELONEPHRITIS 126 0.0148
421 SKIN INJURY 48 0.0147
422 SKIN LACERATION 157 0.0147
423 INCORRECT DOSAGE ADMINISTERED 71 0.0147
424 MALIGNANT MELANOMA 193 0.0146
425 ATRIOVENTRICULAR BLOCK COMPLETE 95 0.0144
426 OSTEOMYELITIS 256 0.0143
427 BONE DENSITY DECREASED 446 0.0143
428 INTERVERTEBRAL DISC DEGENERATION 131 0.0143
429 TOOTH ABSCESS 142 0.0141
430 POOR VENOUS ACCESS 143 0.0140
431 IMMUNOSUPPRESSION 120 0.0140
432 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 352 0.0140
433 THYROID DISORDER 211 0.0139
434 SEPTIC SHOCK 589 0.0138
435 GROIN PAIN 120 0.0138
436 HEPATIC CYST 46 0.0137
437 GLAUCOMA 261 0.0137
438 ORAL CANDIDIASIS 176 0.0137
439 VARICOSE VEIN 70 0.0137
440 LABORATORY TEST ABNORMAL 396 0.0136
441 SPUTUM DISCOLOURED 126 0.0135
442 TENDON DISORDER 87 0.0135
443 MEMORY IMPAIRMENT 1830 0.0135
444 VASCULITIS 155 0.0135
445 SKIN LESION 361 0.0134
446 FLANK PAIN 124 0.0134
447 THROAT CANCER 56 0.0133
448 DYSSTASIA 383 0.0132
449 STRESS 940 0.0132
450 CHEST PAIN 2416 0.0132
451 HAEMATOCRIT DECREASED 257 0.0130
452 SPINAL DISORDER 122 0.0130
453 OFF LABEL USE 11129 0.0130
454 MUSCLE FATIGUE 54 0.0129
455 WOUND SECRETION 50 0.0129
456 DECREASED APPETITE 2940 0.0129
457 INSOMNIA 3359 0.0128
458 SHOULDER OPERATION 53 0.0127
459 LIGAMENT SPRAIN 124 0.0127
460 BEDRIDDEN 165 0.0127
461 HEART RATE DECREASED 442 0.0127
462 DEEP VEIN THROMBOSIS 816 0.0127
463 DRUG SPECIFIC ANTIBODY PRESENT 81 0.0127
464 SECRETION DISCHARGE 154 0.0126
465 OEDEMA PERIPHERAL 1524 0.0126
466 PRODUCT USE IN UNAPPROVED INDICATION 3033 0.0126
467 BLOOD ALBUMIN DECREASED 98 0.0126
468 BLOOD IRON DECREASED 146 0.0125
469 APHTHOUS ULCER 95 0.0125
470 INJECTION SITE INFLAMMATION 61 0.0125
471 MUSCLE SPASTICITY 153 0.0125
472 TUBULOINTERSTITIAL NEPHRITIS 231 0.0125
473 PARAESTHESIA 1937 0.0124
474 LEUKOPENIA 612 0.0124
475 VITAMIN D DECREASED 105 0.0124
476 ANKLE FRACTURE 189 0.0124
477 WHITE BLOOD CELL COUNT INCREASED 469 0.0123
478 VISUAL IMPAIRMENT 1498 0.0123
479 PURULENT DISCHARGE 52 0.0123
480 LYMPHADENOPATHY 425 0.0122
481 MOVEMENT DISORDER 387 0.0122
482 INFLAMMATORY BOWEL DISEASE 118 0.0121
483 MUSCLE STRAIN 103 0.0121
484 PHARYNGITIS 148 0.0120
485 TONSILLITIS 61 0.0119
486 ABSCESS 186 0.0118
487 DEPRESSION 2657 0.0118
488 ORGANISING PNEUMONIA 57 0.0118
489 MUCOUS STOOLS 57 0.0117
490 DIARRHOEA HAEMORRHAGIC 108 0.0117
491 MENINGITIS 77 0.0117
492 NERVE COMPRESSION 106 0.0117
493 EYE DISORDER 377 0.0117
494 ANAL ABSCESS 61 0.0115
495 SWELLING OF EYELID 69 0.0115
496 DRUG EFFECT DECREASED 618 0.0115
497 HYPOCALCAEMIA 213 0.0114
498 MUSCLE SPASMS 2066 0.0114
499 THERAPEUTIC RESPONSE SHORTENED 358 0.0114
500 HEADACHE 7017 0.0114
501 HAEMATOCHEZIA 616 0.0113
502 QUALITY OF LIFE DECREASED 150 0.0113
503 RED BLOOD CELL COUNT DECREASED 319 0.0113
504 POSTOPERATIVE WOUND INFECTION 75 0.0113
505 SKIN INFECTION 124 0.0113
506 HIP SURGERY 59 0.0112
507 CATARACT 656 0.0112
508 GASTROINTESTINAL PAIN 121 0.0112
509 NEPHROLITHIASIS 505 0.0112
510 AFFECTIVE DISORDER 86 0.0111
511 UROSEPSIS 101 0.0111
512 NAUSEA 8585 0.0110
513 DIFFUSE LARGE B-CELL LYMPHOMA 83 0.0110
514 SPINAL COLUMN STENOSIS 52 0.0110
515 BREAST MASS 73 0.0110
516 WEIGHT DECREASED 3022 0.0110
517 LARGE INTESTINE POLYP 75 0.0110
518 NEOPLASM MALIGNANT 719 0.0109
519 SKIN PLAQUE 90 0.0108
520 HAEMOGLOBIN INCREASED 48 0.0108
521 HERNIA 204 0.0107
522 ABDOMINAL PAIN 2443 0.0106
523 OXYGEN SATURATION DECREASED 586 0.0106
524 POST PROCEDURAL INFECTION 85 0.0106
525 SUBCUTANEOUS ABSCESS 50 0.0106
526 PANCREATITIS 551 0.0106
527 DRY EYE 503 0.0105
528 SINUS HEADACHE 62 0.0105
529 SKIN WARM 60 0.0104
530 ABDOMINAL HERNIA 47 0.0104
531 ORAL HERPES 200 0.0104
532 FEELING HOT 630 0.0104
533 INTERVERTEBRAL DISC PROTRUSION 224 0.0104
534 BODY TEMPERATURE INCREASED 209 0.0103
535 RENAL CYST 81 0.0103
536 PELVIC FRACTURE 79 0.0103
537 RESPIRATORY TRACT INFECTION 264 0.0103
538 DIARRHOEA 6536 0.0103
539 TENDON RUPTURE 125 0.0102
540 EYE INFECTION 113 0.0102
541 DECREASED IMMUNE RESPONSIVENESS 98 0.0102
542 UNDERDOSE 729 0.0101
543 RALES 57 0.0099
544 TRANSAMINASES INCREASED 218 0.0099
545 PHOTOPHOBIA 182 0.0099
546 IMMUNE SYSTEM DISORDER 128 0.0099
547 BACK PAIN 2253 0.0098
548 PAIN IN JAW 274 0.0098
549 SQUAMOUS CELL CARCINOMA 91 0.0098
550 CONJUNCTIVITIS 177 0.0098
551 PRE-EXISTING CONDITION IMPROVED 60 0.0096
552 SKIN DISORDER 315 0.0096
553 FISTULA 106 0.0095
554 DYSPNOEA 5295 0.0095
555 LIMB INJURY 253 0.0095
556 STENT PLACEMENT 75 0.0094
557 GASTROINTESTINAL INFECTION 83 0.0094
558 PNEUMONITIS 251 0.0094
559 PNEUMOCYSTIS JIROVECII PNEUMONIA 92 0.0093
560 GENERALISED ERYTHEMA 53 0.0093
561 INGUINAL HERNIA 56 0.0093
562 SPINAL COMPRESSION FRACTURE 77 0.0093
563 CATARACT OPERATION 54 0.0092
564 INCREASED UPPER AIRWAY SECRETION 47 0.0092
565 FUNGAL INFECTION 302 0.0092
566 HEPATITIS B 55 0.0092
567 PRODUCTIVE COUGH 429 0.0092
568 HYPOGAMMAGLOBULINAEMIA 58 0.0092
569 CYSTITIS 289 0.0092
570 ASTHENIA 3386 0.0091
571 MASS 126 0.0091
572 DERMATITIS 185 0.0090
573 DIVERTICULUM 64 0.0090
574 GASTRIC ULCER 169 0.0090
575 RESPIRATORY RATE INCREASED 79 0.0090
576 POLYP 58 0.0090
577 MUSCULOSKELETAL CHEST PAIN 137 0.0090
578 LYMPHOEDEMA 61 0.0090
579 THERAPY PARTIAL RESPONDER 133 0.0089
580 TOOTH DISORDER 197 0.0089
581 NEUTROPENIC SEPSIS 63 0.0089
582 GASTROENTERITIS 128 0.0089
583 CROHN'S DISEASE 61 0.0089
584 HAEMORRHOIDS 171 0.0089
585 HIDRADENITIS 76 0.0089
586 INFLUENZA 976 0.0088
587 INJECTION SITE IRRITATION 110 0.0088
588 RESPIRATORY TRACT CONGESTION 138 0.0088
589 PIGMENTATION DISORDER 53 0.0087
590 PULMONARY EMBOLISM 818 0.0087
591 HAEMOLYTIC ANAEMIA 77 0.0087
592 OROPHARYNGEAL PAIN 792 0.0087
593 PNEUMONIA BACTERIAL 78 0.0087
594 HYPOKINESIA 124 0.0086
595 FEEDING DISORDER 170 0.0086
596 BLOOD PRESSURE INCREASED 1302 0.0086
597 DIZZINESS 4207 0.0086
598 SINUS CONGESTION 114 0.0085
599 DRUG LEVEL BELOW THERAPEUTIC 46 0.0085
600 BONE DISORDER 153 0.0084
601 ODYNOPHAGIA 49 0.0084
602 BLOOD CREATININE INCREASED 542 0.0084
603 THROMBOSIS 668 0.0084
604 SWOLLEN TONGUE 257 0.0083
605 MULTIPLE FRACTURES 135 0.0083
606 BLOOD POTASSIUM INCREASED 132 0.0082
607 CELLULITIS 410 0.0082
608 FURUNCLE 64 0.0082
609 MUCOSAL INFLAMMATION 210 0.0082
610 SCOLIOSIS 50 0.0082
611 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 58 0.0081
612 ORAL PAIN 180 0.0081
613 BLOOD URIC ACID INCREASED 46 0.0081
614 CLOSTRIDIUM DIFFICILE INFECTION 172 0.0080
615 SEASONAL ALLERGY 112 0.0080
616 SPLENOMEGALY 92 0.0080
617 INJECTION SITE HAEMATOMA 115 0.0080
618 IMPAIRED GASTRIC EMPTYING 100 0.0079
619 BLOOD TEST ABNORMAL 110 0.0079
620 ABDOMINAL DISTENSION 809 0.0079
621 INTESTINAL PERFORATION 87 0.0078
622 NEPHROTIC SYNDROME 53 0.0078
623 TOOTH FRACTURE 85 0.0078
624 FEELING JITTERY 147 0.0078
625 DIABETES MELLITUS 587 0.0078
626 DUODENAL ULCER 54 0.0078
627 HAND FRACTURE 54 0.0077
628 SEPSIS 847 0.0077
629 ECZEMA 381 0.0077
630 HAEMOGLOBIN DECREASED 779 0.0077
631 HYSTERECTOMY 65 0.0076
632 STAPHYLOCOCCAL INFECTION 249 0.0076
633 FLUID RETENTION 381 0.0076
634 LARGE INTESTINE PERFORATION 52 0.0076
635 HYPOTHYROIDISM 238 0.0076
636 PLEURAL EFFUSION 454 0.0076
637 AFFECT LABILITY 72 0.0075
638 UPPER-AIRWAY COUGH SYNDROME 61 0.0075
639 RHINORRHOEA 479 0.0075
640 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1309 0.0075
641 COVID-19 PNEUMONIA 88 0.0075
642 BODY HEIGHT DECREASED 80 0.0075
643 KIDNEY INFECTION 145 0.0075
644 TACHYCARDIA 654 0.0075
645 ORAL DISORDER 54 0.0074
646 IRON DEFICIENCY ANAEMIA 67 0.0074
647 PURPURA 64 0.0073
648 WRIST FRACTURE 86 0.0073
649 NASAL CONGESTION 419 0.0073
650 RASH MACULO-PAPULAR 158 0.0072
651 COLON CANCER 106 0.0072
652 VITAMIN D DEFICIENCY 69 0.0072
653 ERYTHEMA 1450 0.0072
654 SCRATCH 73 0.0071
655 CYTOPENIA 84 0.0071
656 HYPOKALAEMIA 322 0.0071
657 COUGH 1947 0.0071
658 UTERINE LEIOMYOMA 51 0.0070
659 DRUG LEVEL DECREASED 71 0.0070
660 DRUG RESISTANCE 178 0.0070
661 VERTIGO 419 0.0070
662 TINNITUS 316 0.0070
663 LUNG INFECTION 108 0.0069
664 HEART RATE INCREASED 677 0.0069
665 FRACTURE 129 0.0069
666 AGRANULOCYTOSIS 125 0.0069
667 MOTOR DYSFUNCTION 68 0.0068
668 COLITIS 253 0.0068
669 TOOTHACHE 121 0.0068
670 PHARYNGITIS STREPTOCOCCAL 72 0.0067
671 HIATUS HERNIA 86 0.0067
672 POOR QUALITY SLEEP 141 0.0067
673 FALL 2181 0.0066
674 GASTROINTESTINAL INFLAMMATION 51 0.0066
675 EMPHYSEMA 66 0.0066
676 VIRAL INFECTION 214 0.0065
677 TOXIC EPIDERMAL NECROLYSIS 97 0.0065
678 DRUG USE DISORDER 53 0.0065
679 HEART RATE IRREGULAR 145 0.0065
680 DEAFNESS 167 0.0065
681 INFLUENZA LIKE ILLNESS 526 0.0065
682 BACTERIAL INFECTION 118 0.0064
683 PRODUCT QUALITY ISSUE 850 0.0064
684 HYPERTENSIVE CRISIS 70 0.0064
685 BLOOD DISORDER 50 0.0063
686 RIB FRACTURE 128 0.0063
687 NEUTROPHIL COUNT INCREASED 64 0.0063
688 LOSS OF CONSCIOUSNESS 798 0.0063
689 SKIN CANCER 134 0.0063
690 MACULAR DEGENERATION 74 0.0063
691 BLOOD PRESSURE ABNORMAL 123 0.0063
692 HAEMOLYSIS 48 0.0063
693 UPPER LIMB FRACTURE 124 0.0063
694 SPINAL OPERATION 75 0.0063
695 TOOTH LOSS 129 0.0063
696 INTRAOCULAR PRESSURE INCREASED 79 0.0062
697 STEVENS-JOHNSON SYNDROME 137 0.0062
698 ANXIETY 1754 0.0062
699 URINARY TRACT INFECTION 1044 0.0062
700 PNEUMOTHORAX 97 0.0062
701 ILLNESS 609 0.0061
702 EYE INFLAMMATION 57 0.0061
703 TREATMENT NONCOMPLIANCE 326 0.0061
704 SARS-COV-2 TEST POSITIVE 80 0.0061
705 RENAL IMPAIRMENT 499 0.0060
706 ACCIDENT 71 0.0060
707 GASTRIC HAEMORRHAGE 69 0.0060
708 FOETAL EXPOSURE DURING PREGNANCY 482 0.0060
709 FEMUR FRACTURE 184 0.0060
710 NIGHTMARE 206 0.0060
711 RENAL DISORDER 274 0.0059
712 PANCYTOPENIA 327 0.0059
713 RENAL FAILURE 784 0.0059
714 INTESTINAL OBSTRUCTION 219 0.0059
715 GASTRITIS 153 0.0059
716 EJECTION FRACTION DECREASED 90 0.0059
717 COVID-19 1022 0.0059
718 FACIAL PARALYSIS 49 0.0059
719 PALPITATIONS 675 0.0058
720 WHITE BLOOD CELL COUNT DECREASED 623 0.0058
721 INJECTION SITE PRURITUS 381 0.0058
722 SCAR 98 0.0058
723 SWELLING FACE 370 0.0058
724 GAMMA-GLUTAMYLTRANSFERASE INCREASED 126 0.0058
725 HEPATOMEGALY 56 0.0057
726 MITRAL VALVE INCOMPETENCE 64 0.0057
727 CHOLECYSTECTOMY 64 0.0057
728 BLOOD ALKALINE PHOSPHATASE INCREASED 140 0.0057
729 POST PROCEDURAL COMPLICATION 108 0.0057
730 NERVE INJURY 62 0.0056
731 RASH ERYTHEMATOUS 260 0.0056
732 CHOLELITHIASIS 182 0.0056
733 BURNING SENSATION 387 0.0056
734 NEUROPATHY PERIPHERAL 520 0.0056
735 INJECTION SITE WARMTH 113 0.0056
736 TEMPERATURE INTOLERANCE 55 0.0055
737 DISEASE RECURRENCE 256 0.0054
738 GALLBLADDER DISORDER 96 0.0054
739 BREAST CANCER 500 0.0054
740 BRONCHOSPASM 76 0.0054
741 INTENTIONAL DOSE OMISSION 145 0.0054
742 LYMPHOCYTE COUNT DECREASED 93 0.0053
743 CHILLS 613 0.0053
744 SCAB 59 0.0053
745 THYROID CANCER 63 0.0053
746 SLEEP APNOEA SYNDROME 99 0.0052
747 POLYNEUROPATHY 61 0.0052
748 PHARYNGEAL SWELLING 49 0.0052
749 SNEEZING 114 0.0052
750 BLOOD LACTATE DEHYDROGENASE INCREASED 81 0.0051
751 MOOD SWINGS 161 0.0051
752 NEURALGIA 122 0.0051
753 LOCAL SWELLING 89 0.0051
754 SKIN DISCOLOURATION 231 0.0051
755 INCORRECT PRODUCT ADMINISTRATION DURATION 102 0.0051
756 DYSPHONIA 293 0.0051
757 CARDIOMEGALY 61 0.0050
758 DISSEMINATED INTRAVASCULAR COAGULATION 69 0.0050
759 INJECTION SITE BRUISING 385 0.0049
760 RENAL TUBULAR NECROSIS 48 0.0049
761 PROTEINURIA 92 0.0049
762 GLOMERULAR FILTRATION RATE DECREASED 59 0.0049
763 BLOOD URINE PRESENT 92 0.0049
764 INJECTION SITE SWELLING 360 0.0048
765 PHARYNGEAL OEDEMA 74 0.0048
766 CRYING 173 0.0048
767 ANGIOEDEMA 207 0.0048
768 SKIN FISSURES 88 0.0047
769 CORONARY ARTERY OCCLUSION 64 0.0047
770 SMALL INTESTINAL OBSTRUCTION 57 0.0047
771 ACNE 353 0.0047
772 GENERALISED OEDEMA 57 0.0047
773 MYOCARDIAL ISCHAEMIA 53 0.0047
774 PROCEDURAL PAIN 126 0.0046
775 ACTIVITIES OF DAILY LIVING IMPAIRED 91 0.0046
776 PETECHIAE 47 0.0046
777 APHONIA 63 0.0046
778 INJECTION SITE DISCOLOURATION 56 0.0046
779 ANGINA PECTORIS 130 0.0046
780 DYSPNOEA EXERTIONAL 169 0.0046
781 SINUS DISORDER 89 0.0045
782 INJECTION SITE EXTRAVASATION 56 0.0045
783 HEAD DISCOMFORT 79 0.0045
784 DECREASED ACTIVITY 48 0.0045
785 PRODUCT PRESCRIBING ERROR 106 0.0045
786 FEELING ABNORMAL 1074 0.0045
787 FACE OEDEMA 75 0.0045
788 OESOPHAGITIS 48 0.0044
789 MUSCLE TIGHTNESS 71 0.0044
790 CORONARY ARTERY DISEASE 132 0.0044
791 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 224 0.0044
792 INJECTION SITE ERYTHEMA 529 0.0043
793 OCULAR HYPERAEMIA 200 0.0043
794 FEELING COLD 119 0.0043
795 TOOTH EXTRACTION 53 0.0043
796 INJECTION SITE RASH 129 0.0043
797 EOSINOPHILIA 74 0.0043
798 HEPATIC FUNCTION ABNORMAL 157 0.0043
799 CARDIOVASCULAR DISORDER 108 0.0043
800 SYNCOPE 422 0.0043
801 LIP SWELLING 140 0.0043
802 LUNG NEOPLASM MALIGNANT 174 0.0043
803 CHOLECYSTITIS 50 0.0043
804 MIDDLE INSOMNIA 78 0.0042
805 EMOTIONAL DISORDER 130 0.0042
806 ABDOMINAL PAIN LOWER 106 0.0042
807 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 231 0.0042
808 INJECTION SITE PAIN 1249 0.0042
809 SPINAL FRACTURE 82 0.0042
810 EYE PAIN 227 0.0042
811 HOSPITALISATION 625 0.0042
812 PERICARDIAL EFFUSION 94 0.0041
813 MYALGIA 690 0.0041
814 LEUKOCYTOSIS 73 0.0041
815 UNEVALUABLE EVENT 305 0.0041
816 HYPERLIPIDAEMIA 48 0.0041
817 MYOCARDIAL INFARCTION 681 0.0039
818 PULMONARY OEDEMA 173 0.0039
819 FAECES DISCOLOURED 83 0.0039
820 ANAPHYLACTIC SHOCK 98 0.0039
821 THROAT IRRITATION 170 0.0039
822 PELVIC PAIN 69 0.0038
823 DYSGEUSIA 283 0.0038
824 SOMNOLENCE 750 0.0038
825 CARDIOMYOPATHY 55 0.0038
826 EATING DISORDER 79 0.0037
827 HEAD INJURY 116 0.0037
828 ACUTE RESPIRATORY DISTRESS SYNDROME 65 0.0037
829 BLOOD PRESSURE DECREASED 243 0.0037
830 GOUT 65 0.0037
831 HYPOTENSION 723 0.0037
832 ANAEMIA 687 0.0036
833 JAUNDICE 97 0.0036
834 ACUTE MYOCARDIAL INFARCTION 106 0.0036
835 HYPERHIDROSIS 458 0.0036
836 INJECTION SITE URTICARIA 86 0.0036
837 FEAR 96 0.0036
838 RASH MACULAR 123 0.0036
839 DEVICE RELATED INFECTION 54 0.0035
840 PRESYNCOPE 84 0.0035
841 OSTEONECROSIS 115 0.0035
842 RASH GENERALISED 91 0.0035
843 HYPOAESTHESIA ORAL 52 0.0035
844 THROMBOCYTOPENIA 382 0.0035
845 RESPIRATORY FAILURE 249 0.0035
846 INJECTION SITE HAEMORRHAGE 268 0.0034
847 CHEST DISCOMFORT 344 0.0034
848 CHROMATURIA 76 0.0034
849 HAEMOPTYSIS 94 0.0034
850 BONE PAIN 196 0.0034
851 BLOOD POTASSIUM DECREASED 99 0.0033
852 NERVOUS SYSTEM DISORDER 102 0.0033
853 EYE SWELLING 120 0.0033
854 HYPOPHAGIA 81 0.0032
855 NEUTROPENIA 432 0.0032
856 CYTOMEGALOVIRUS INFECTION 53 0.0032
857 THROAT TIGHTNESS 86 0.0032
858 CHRONIC KIDNEY DISEASE 242 0.0032
859 HAEMATEMESIS 80 0.0032
860 RASH PAPULAR 70 0.0032
861 PALLOR 85 0.0032
862 PLATELET COUNT DECREASED 331 0.0031
863 MENTAL DISORDER 135 0.0031
864 ABORTION SPONTANEOUS 124 0.0031
865 UPPER GASTROINTESTINAL HAEMORRHAGE 52 0.0031
866 SUICIDAL IDEATION 280 0.0031
867 BLOOD CREATINE PHOSPHOKINASE INCREASED 89 0.0031
868 BONE MARROW FAILURE 62 0.0031
869 BALANCE DISORDER 262 0.0031
870 SURGERY 174 0.0030
871 ARRHYTHMIA 142 0.0030
872 CARDIAC DISORDER 280 0.0030
873 INTENTIONAL PRODUCT MISUSE 258 0.0030
874 LETHARGY 169 0.0030
875 BREAST CANCER FEMALE 79 0.0030
876 HYPOACUSIS 126 0.0030
877 ABASIA 73 0.0030
878 PAIN OF SKIN 78 0.0029
879 HIP FRACTURE 92 0.0029
880 DEPRESSED MOOD 150 0.0029
881 COLD SWEAT 50 0.0029
882 DYSURIA 104 0.0029
883 DRUG INTERACTION 447 0.0029
884 THERAPEUTIC RESPONSE UNEXPECTED 126 0.0028
885 CHOKING 54 0.0028
886 ACUTE RESPIRATORY FAILURE 53 0.0028
887 CARDIAC FAILURE CONGESTIVE 224 0.0028
888 ATRIAL FIBRILLATION 267 0.0028
889 CONSTIPATION 592 0.0028
890 EYE IRRITATION 152 0.0028
891 PRODUCT DISPENSING ERROR 59 0.0027
892 CEREBROVASCULAR ACCIDENT 461 0.0027
893 FLUSHING 276 0.0027
894 EYE PRURITUS 89 0.0027
895 PRODUCT DOSE OMISSION IN ERROR 72 0.0027
896 MULTI-ORGAN FAILURE 47 0.0027
897 DYSPHAGIA 252 0.0027
898 POLLAKIURIA 110 0.0027
899 ACUTE KIDNEY INJURY 400 0.0027
900 INCORRECT DOSE ADMINISTERED 590 0.0027
901 MENORRHAGIA 52 0.0026
902 HOT FLUSH 196 0.0026
903 PULMONARY HYPERTENSION 54 0.0026
904 RESTLESS LEGS SYNDROME 47 0.0026
905 HEPATIC FAILURE 78 0.0026
906 OVERDOSE 559 0.0026
907 ASCITES 75 0.0026
908 EPISTAXIS 191 0.0026
909 FLATULENCE 144 0.0026
910 SKIN EXFOLIATION 210 0.0026
911 DISEASE PROGRESSION 297 0.0026
912 DEVICE MALFUNCTION 169 0.0025
913 PRURITUS GENERALISED 55 0.0025
914 SPEECH DISORDER 131 0.0025
915 MYELOSUPPRESSION 85 0.0025
916 NEUTROPHIL COUNT DECREASED 100 0.0025
917 TRANSIENT ISCHAEMIC ATTACK 83 0.0025
918 URINARY RETENTION 81 0.0025
919 CEREBRAL INFARCTION 59 0.0024
920 MELAENA 53 0.0024
921 HAEMORRHAGE 251 0.0024
922 RETCHING 51 0.0024
923 DEHYDRATION 318 0.0024
924 HAEMATOMA 62 0.0024
925 TREMOR 392 0.0024
926 BLINDNESS 96 0.0024
927 AGEUSIA 58 0.0024
928 MOOD ALTERED 62 0.0023
929 CARDIAC FAILURE 183 0.0023
930 NEEDLE ISSUE 65 0.0023
931 GASTROINTESTINAL HAEMORRHAGE 191 0.0023
932 INJECTION SITE MASS 83 0.0023
933 PANCREATITIS ACUTE 50 0.0023
934 NERVOUSNESS 117 0.0023
935 PANIC ATTACK 81 0.0022
936 HAEMATURIA 76 0.0022
937 URINARY INCONTINENCE 65 0.0022
938 PRODUCT AVAILABILITY ISSUE 49 0.0022
939 WRONG TECHNIQUE IN DRUG USAGE PROCESS 80 0.0022
940 HYPONATRAEMIA 117 0.0021
941 PRODUCT DOSE OMISSION 136 0.0021
942 TOXICITY TO VARIOUS AGENTS 337 0.0020
943 VISION BLURRED 273 0.0020
944 MULTIPLE SCLEROSIS 96 0.0020
945 PRODUCT DOSE OMISSION ISSUE 565 0.0020
946 PROSTATE CANCER 160 0.0020
947 PNEUMONIA ASPIRATION 49 0.0020
948 PREMATURE BABY 59 0.0020
949 HYPOXIA 68 0.0020
950 DIPLOPIA 49 0.0019
951 RENAL FAILURE ACUTE 80 0.0019
952 RENAL INJURY 55 0.0019
953 DRY SKIN 239 0.0018
954 DEVICE ISSUE 158 0.0018
955 BLOOD GLUCOSE INCREASED 339 0.0018
956 MULTIPLE ORGAN DYSFUNCTION SYNDROME 50 0.0018
957 APHASIA 54 0.0018
958 LACRIMATION INCREASED 53 0.0018
959 FEBRILE NEUTROPENIA 117 0.0018
960 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 126 0.0018
961 THERAPY INTERRUPTED 120 0.0018
962 BLOOD BILIRUBIN INCREASED 47 0.0018
963 DRUG EXPOSURE DURING PREGNANCY 56 0.0016
964 SEIZURE 184 0.0016
965 DRUG DOSE OMISSION 260 0.0016
966 HYPERGLYCAEMIA 56 0.0016
967 HALLUCINATION 114 0.0015
968 DYSARTHRIA 57 0.0015
969 DYSKINESIA 59 0.0015
970 NO ADVERSE EVENT 256 0.0015
971 ACCIDENTAL EXPOSURE TO PRODUCT 128 0.0013
972 COGNITIVE DISORDER 59 0.0013
973 DISTURBANCE IN ATTENTION 68 0.0013
974 AGITATION 92 0.0013
975 DEATH 1026 0.0012
976 COMA 56 0.0012
977 VAGINAL HAEMORRHAGE 50 0.0012
978 THERAPY CESSATION 60 0.0012
979 BRADYCARDIA 61 0.0012
980 CARDIAC ARREST 90 0.0011
981 IRRITABILITY 64 0.0011
982 EMOTIONAL DISTRESS 129 0.0011
983 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 211 0.0011
984 HYPOGLYCAEMIA 50 0.0010
985 CONVULSION 58 0.0010
986 SKIN BURNING SENSATION 71 0.0010
987 PRODUCT STORAGE ERROR 68 0.0008
988 DRUG DEPENDENCE 113 0.0007